Neuroendocrine Tumor Treatment Market Segmentation
The Neuroendocrine Tumor Treatment Market segmentation is primarily based on therapy type, tumor type, and end user. By therapy, the market includes somatostatin analogs, targeted therapy, chemotherapy, and radiotherapy. Among these, targeted therapies and peptide receptor radionuclide therapy (PRRT) are gaining traction due to their enhanced efficacy and reduced side effects.
https://www.prnewsreleaser.com/news/261803
Like
Comment
Share
